Analysts expect Orthofix International N.V. (NASDAQ:OFIX) to announce $0.50 earnings per share for the current quarter, according to Zacks. Two analysts have issued estimates for Orthofix International’s earnings, with the highest EPS estimate coming in at $0.51 and the lowest estimate coming in at $0.48. Orthofix International posted earnings of $0.42 per share during the same quarter last year, which would indicate a positive year-over-year growth rate of 19%. The company is scheduled to issue its next earnings report on Monday, February 26th.
According to Zacks, analysts expect that Orthofix International will report full-year earnings of $1.61 per share for the current financial year, with EPS estimates ranging from $1.60 to $1.62. For the next fiscal year, analysts expect that the company will report earnings of $1.83 per share, with EPS estimates ranging from $1.80 to $1.90. Zacks’ EPS calculations are an average based on a survey of sell-side research firms that cover Orthofix International.
Orthofix International (NASDAQ:OFIX) last issued its quarterly earnings results on Monday, October 30th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.41 by $0.01. Orthofix International had a return on equity of 10.26% and a net margin of 0.33%. The business had revenue of $105.30 million for the quarter, compared to analyst estimates of $100.67 million. During the same quarter in the prior year, the firm posted $0.36 earnings per share. The firm’s revenue for the quarter was up 6.9% compared to the same quarter last year.
Several equities analysts have recently issued reports on OFIX shares. BTIG Research set a $56.00 price target on Orthofix International and gave the company a “buy” rating in a research note on Monday, October 30th. Zacks Investment Research raised Orthofix International from a “hold” rating to a “buy” rating and set a $60.00 price target on the stock in a research note on Thursday, November 2nd. TheStreet lowered Orthofix International from a “b” rating to a “c+” rating in a research note on Tuesday, October 31st. Finally, BidaskClub raised Orthofix International from a “sell” rating to a “hold” rating in a research note on Thursday, December 21st. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $54.42.
Shares of Orthofix International (OFIX) traded down $0.36 on Friday, hitting $54.58. The stock had a trading volume of 138,050 shares, compared to its average volume of 83,033. Orthofix International has a twelve month low of $33.51 and a twelve month high of $56.53. The firm has a market capitalization of $998.33, a price-to-earnings ratio of 779.83, a PEG ratio of 2.38 and a beta of 0.14.
In other Orthofix International news, insider Bradley V. Niemann sold 5,547 shares of the stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $52.08, for a total value of $288,887.76. Following the completion of the sale, the insider now directly owns 34,631 shares in the company, valued at $1,803,582.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Brad Mason sold 5,000 shares of the stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $53.48, for a total value of $267,400.00. Following the completion of the sale, the chief executive officer now owns 183,053 shares of the company’s stock, valued at $9,789,674.44. The disclosure for this sale can be found here. Insiders sold 15,347 shares of company stock valued at $802,144 over the last 90 days. Corporate insiders own 5.60% of the company’s stock.
Several institutional investors have recently made changes to their positions in the business. Invictus RG bought a new stake in shares of Orthofix International in the third quarter worth about $342,000. Oakview Capital Management L.P. bought a new position in shares of Orthofix International during the third quarter worth about $12,756,000. OxFORD Asset Management LLP grew its holdings in shares of Orthofix International by 8.9% during the third quarter. OxFORD Asset Management LLP now owns 81,386 shares of the medical device company’s stock worth $3,852,000 after buying an additional 6,647 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Orthofix International by 1.2% during the third quarter. Dimensional Fund Advisors LP now owns 880,901 shares of the medical device company’s stock worth $41,623,000 after buying an additional 10,781 shares in the last quarter. Finally, WINTON GROUP Ltd bought a new position in shares of Orthofix International during the third quarter worth about $2,121,000. Institutional investors own 94.61% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “$0.50 Earnings Per Share Expected for Orthofix International N.V. (OFIX) This Quarter” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this news story on another website, it was illegally copied and reposted in violation of international copyright & trademark laws. The original version of this news story can be read at https://ledgergazette.com/2018/01/09/0-50-earnings-per-share-expected-for-orthofix-international-n-v-ofix-this-quarter.html.
Orthofix International Company Profile
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthofix International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International and related companies with MarketBeat.com's FREE daily email newsletter.